The effects of a dietary intake of gamma-linolenic acid 18: 3 n-6 (GLA) on blood lipids and phospholipid fatty acids were studied in 25 healthy men. The study was conducted over 4 one-month periods during which the subjects maintained their usual diet of about 2,780 kcal per day consisting of 54.4% carbohydrates, 13.5% proteins, and 32.1% lipids, the last of which included 13% in the form of vegetable oils (40g) and 328 mg of cholesterol. The vegetable oil, the only parameter which was varied during the study, was soybean oil during the 1st and 4th periods, not providing GLA, and rapeseed oil and evening primrose oil in the proportion of 2 : 1 during the 2nd period, providing 1.1 g of GLA per day, and I : I during the 3rd period, providing 1.6 g of GLA per day. The intake of other fatty acids was maintained as constant as possible throughout the study. The administration of GLA was accompanied by a dose-dependent reduction in LDL cholesterol (-10% with 1.1 g of GLA and -25% with 1.6 g of GLA) and a significant increase in HDL cholesterol (+7 and +9%, respectively). Triglycerides, phospholipids, and apoprotein B did not vary significantly, while apoprotein AI was markedly increased (+20 and +20%, respectively). In terms of the serum phospholipid fatty acids, the GLA ingestion was also accompanied by dose-dependent decrease in linoleic acid and increases in all its derivatives. Heterogeneous variations were observed in the n-3 derivatives: the 20: 5 n-3 was decreased but the 22: 5 n-3 and the 22: 6 n-3 remained stable. A decrease was observed for the 18 : 0 and the 24: 0, while the 18 : 1 n-9 was increased. These results indicate that dietary gamma-linolenic acid is more efficient in reducing serum LDL cholesterol than dietary linoleic acid.
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The physiological importance of essential fatty acids and polyunsaturated fatty acids derivatives of C20 and C22 has been recognized for a long time. Their role has been demonstrated in cellular energetic metabolism, in the structures of cell membranes with certain tissue specificities of fatty acids and, lastly, in intracellular synthesis of important mediators, the "icosanoids." All of these activities depend on endocrino-metabolic regulations.
The blood lipid levels are closely correlated with the dietary intake of fatty acids. Keys and Hegsted were the first to propose equations allowing prediction of the effects of a dietary intake of saturated and polyunsaturated acids on blood cholesterol levels [1, 2] . Attention rapidly became focused on linoleic acid, for which a hypocholesterolemic effect was demonstrated [3] . More recently, linoleic acid derivatives, particularly gamma-linolenic acid ((ALA), were found to have even more potent effects on the reduction of blood cholesterol [4, 5] . This has been confirmed in animals and is currently being evaluated in man [6] [7] [8] [9] .
There is a limiting step in the transformation of linoleic acid into its derivatives, and it is situated at the level of the delta-6 desaturation [10] . This could be altered in certain disease states, such as diabetes and alcoholism, or during ageing, resulting in COLA deficiency. Such deficiency possibly results in an imbalance between the synthesis of prostaglandins PG1 and PG2 which are involved in, amongst other processes, platelet aggregation [11] . A more detailed study of the metabolism of n-6 derivatives should provide information concerning the mechanisms involved in the reduction in blood cholesterol related to a dietary intake of polyunsaturated fats and should improve the nutritional guidelines for the prevention of cardiovascular diseases.
The proposed dietary allowance of linoleic acid amounts to 1-2% of total calories [12] . This study was designed to measure the effects on blood lipids of 2 doses of GLA, 1.1 and 1.6g. Theoretically, if an effective transformation occurs, the same amount of (ALA would be provided by an intake of 3-4 g of linoleic acid, about 1 % of dietary calories in our study, in healthy men receiving a perfectly stabilized diet [13] . MATERIALS 
AND METHODS
Subjects. This study was conducted in a religious rural community of men. The participants gave their informed consent. Twenty-five men were entered into study (mean age 57±12 years; mean height, 171-6 cm; and mean weight, 65±7 kg Protocol. The study was conducted over 4 one-month periods. The subjects maintained their usual diet with 40 g of one or a mixture of the following vegetable oils : first period, soybean oil; second period, rapeseed oil and evening primrose oil in the proportion of 2: l; third period, rapeseed oil and evening primrose oil in the proportion of 1 : 1; fourth period, soybean oil.
Lipids surveys were performed at the end of the 4 periods; and phospholipid fatty acids, at the end of the first 3 periods.
Daily caloric intake. During the first period of the study, the daily caloric intake was estimated on the basis of the weekly dietary intake of the community. The nutrient composition was evaluated with the help of recent food composition tables [14, 15] . The mean daily caloric intake was 2,780 kcal. The distribution of nutrients was as follows: the mean protein intake was 13.5% of the total caloric intake (6.1% of animal origin and 7.4% of vegetable origin); the mean lipid intake, 32.1% of the total, with 13% as oils (40 g); and the mean carbohydrate intake, 54.4% of the total. The mean cholesterol intake was 328 mg/day.
The fatty acid composition of the diets is shown in Table 1 . For the two periods with soybean oil, there was no GLA supplementation. For the second period, the evening primrose oil provided 1.1 g of GLA per day, and for the third period, 1.6 g per day.
Laboratory assays. For the laboratory tests, blood was collected from the arm by venous puncture at 7 a.m. in subjects who had fasted for 12 h. Serum was collected by decantation and stored at 7°C. The following blood parameters were measured: IC and free cholesterol (FC) by a colorimetric enzymatic method (kits from Boehringer Mannheim); HDL-C by selective precipitation of VLDL and LDL by dextran-magnesium, according to the catalase method (kit from Boehringer Mannheim); esterified cholesterol (EC), calculated by difference; TG and phospholipids (PL) by a colorimetric enzymatic method (kits from Wako Chemicals, Osaka); apoproteins Al and B by laser immuno-nephelometry [16] . LDL-C was calculated according to Friedewald's formula:"LDL-C=TC HDL-C TG/ 5 [17] .
Fatty acids of the serum phospholipids were analyzed by the following method: serum lipids were extracted with chloroform/methanol (2/I, v/v) according to the method of Folch et al. [18] . Lipids were then separated by thin-layer chromatography on a silica gel plate; the solvent was a mixture of petroleum ether/ diethyl ether acetic acid (90/30/ 1, v/v/v). The phospholipids fraction was identified after staining with rhodamine and comparison with known standards. Heptadecanoic acid was added to the collected fraction as an internal standard, and this fraction was transmethylated with a methanol/benzene/sulfuric acid solution (100/0.2/2, v/v/v). The mixture of fatty acid methyl esters was analyzed on a CARL® ERBA 4100 gas chromatograph using a temperature program of 2.5°C/min from 135 to 210°C. The injector was a Ross type; its temperature was 260°C. The auxiliary gases were hydrogen and air, and the carrier gas was helium. A 50-meter capillary column was used; its stationary phase was CP SIL 88. Peak areas were measured by a D E L S I EN I C A 10 integrator recorder.
Statistical analysis. The mean values were compared by two-way analysis of variance (period x subjects), completed in case of significant period effect by the Newman-Keuls test [19] .
RESULTS

Clinical parameters
Body weight did not vary during the study (66.1±7.4, 66.1±7.5, 65.2±7.6, and 65.9± 7.7 kg, respectively, for the 4 periods).
Blood lipids
The results of analysis of blood lipids are shown in Table 2 . After the period supplying 1.1 g of COLA per day, we observed a significant decrease for LDL-C (mean of -10%), but a non significant one for TC (mean of -5%), while HDL-C was significantly increased (mean of + 7%). These changes were clearly confirmed and amplified after the following period that provided 1.6 g of COLA per day: LDL-C, mean of -25%; TC, mean of -14%; and H D L-C, mean of +9%. Significant variations were also observed in free and esterified cholesterol at the end of the second period (mean of -12 and -16%, respectively). It should be stressed that the results concerning TC and its various components were not significantly different between the two soybean oil periods without GLA ingestion. TG and PL did not vary significantly during the four periods.
Apoprotein Al was very markedly increased (mean of x-20%) during the 2nd period with 1.1 g of GLA per day and remained stable (mean of +20%) during the following period with 1.6 g of GLA. No significant variation was observed for apoprotein B. The results concerning these parameters did not reveal any significant difference between the two soybean oil periods.
Phospholipid fatty acids
The results of analysis of phospholipid fatty acids are shown in Table 3 . greater after the 3rd period supplying 1.6 g of GLA, especially for 18 : 2 n-6, 20: 3 n-6, 20: 4 n-6, and 22 : 4 n-6. In the n-3 family of fatty acids, a decrease in the levels of 18 : 3 n-3 and 20: 5 n-3 was observed without any significant modification in 22: 5 n-3 and 22: 6 n-3. Sum of 18: 3 n-3 metabolites did not show any significant variation. The levels of saturated fatty acids 18:0 and 24:0 were slightly decreased; the level of 20 : 0 was increased. Lastly, the level of 18 : 1 n-9 was slightly increased. SFA were significantly decreased; and MUFA, increased.
DISCUSSION
This study was conducted on a homogeneous population of healthy men. At the four periods, body weight remained stable. The stability of the lifestyle and dietary habits of the subjects ensured their perfect compliance. The characteristics of the diet were very similar to the recommendations of the National Institutes of Health, considered to be appropriate for the prevention of cardiovascular diseases [20] . This study differs from earlier studies in the quantity of GLA administered (1.1 and 1.6 g per day), corresponding to one of the highest intakes studied in man (ranging from 180 mg to 2.O g per day). The effect of GLA on blood lipids consisted of a dose-dependent decrease in TC and LDL-C without modification of apoprotein P and a strong increase in apoprotein Al with a slight increase in HDL-C. GLA intake was accompanied, in terms of phospholipid fatty acids, by increases in the levels of GLA, but, more importantly, in its metabolites 20 : 3 n-6 and 20: 4 n-6, and a decreae in 18 : 2 n-6. The level of 20: 5 n-3 was slightly decreased, while the levels of higher n-3 derivatives remained stable. The level of 18 : 0 decreased slightly, while the level of 18 : 1 n-9 was markedly increased, possibly induced by the higher intake of monounsaturated fatty acids from the rapeseed oil. Most of these changes appeared to be dose-dependent. The significant increase in the 20: 3 n-6/20: 4 n-6 ratio (Table 4) testifies to the regulation of the 20 : 4 n-6 level, even if in parallel, the decrease in 20 : 5 n-3 can be explained by a preferential delta-5 desaturation of 20 : 3 n-6, which is strongly increased. But this did not seem to influence 20 : 5 n-3 derivatives since 22 : 5 n-3 remained stable. Furthermore the balance between n-6 and n-3 families was maintained as illustrated by the stability of the 20 : 3 n-6+20 : 5 n-3+22 : 6 n-3/20 : 4 n-6 ratio. Under our study conditions, the GLA supply was not in excess and phospholipid fatty acid modifications in serum remained in the physiological range. The effects of GLA intake on blood lipids have not always been demonstrated so clearly in previous studies. Horrobin and Manku [4] reported the effect of GLA on blood cholesterol after 3 months of supplementation to be an increasing reduction according to the dose administered: 180, 360, and 540 mg per day. Their study was conducted on 3 samples of patients: hyperlipidemic patients, obese patients, and patients treated for eczema. In these 3 groups, the effects reported were only significant in the patients with an initial blood cholesterol level greater than I .94 g/liter. Moreover, the decrease in cholesterol was obtained at the expense of LDL-C, and no effect was observed in HDL-C. Chantreuil et al. [5] also demonstrated that the administration of 2 g of GLA per day for 6 weeks decreased TC and TG in diabetic patients receiving a diet composed of 45°c lipid calories, including 1 /3 polyunsaturated fats. In contrast, the administration of 500 mg of GLA did not induce any significant modification. In a previous study in postinfarction patients receiving 480 mg of GLA per day for 1 year, Jacotot et al. [21] reported an increase in PIDL-C without any variation in TC. For Boberg et al. [22] , the administration of 360 mg of GLA per day for 2 months to hypertriglyceridemic patients did not induce any modification in either TC or TG. They explained this lack of effect as due to the fact that the diet was already rich in linoleic acid. In actual fact, the linoleic acid levels in phospholipids were very similar in his study and in our own, where the linoleic acid intake represented between 7 and 8% of the calories, which can be considered to be fairly high intake, and where the blood lipid changes were particularly marked. Viikari and Lethonen [23] also did not observe any variation in blood lipids in hyperlipidemic patients receiving 3 successive doses of GLA, 200, 400, and 600 mg per day, administered for one month each. Ishikawa et al. [24] observed significant changes in plasma lipids after administration of 300 mg per day of GLA to hypercholesterolemic patients over an 8-week period. IC, LDL-C, and apoprotein P were decreased in patients without hypertriglyceridemia, and HDL-C and apoprotein A1(Hf-7%, not significant) were increased in patients with hypertriglyceridemia. The effects on blood cholesterol therefore appear to be clearly related to the dose of GLA administered.
In contrast, significant modifications in fatty acids have been constantly observed. Paccalin et al. [25] reported increased levels of GLA in cholesterol esters and increased levels of 20 : 3 n-6 in cholesterol esters and phospholipids in cirrhotic patients following a diet containing 400 mg of GLA per day for 3 weeks. Chantreuil et al. [5] also reported increases in the sum of 18 : 3 n-6, 20 : 3 n-6, and Vol. 8, No. 1, 1990 20 : 4 n-6 in triglycerides, phospholipids, and cholesterol esters. In a study conducted in schizophrenic patients with a daily intake of 200 mg of GLA for 12 months, Bourguignon et al. [26] observed significant increases in the levels of GLA in cholesterol esters and in the level of 20 : 3 n-6 in cholesterol esters and phospholipids by the 3rd month of treatment. Boberg et al. [22] reported that even in the absence of any modification in TC, there were nevertheless increases in the levels of GLA in cholesterol esters and triglycerides and increases in the levels of 20 : 3 n-6 in these fractions as well as in serum and platelet phospholipids, without any variation in the level of 20 : 4 n-6. These changes were accompanied by a decrease in the level of 18 : 1 n-9, without any variation in the levels of n-3 fatty acids. Viikari and Lethonen [23] also reported significant increases in the levels of GLA in triglycerides, cholesterol esters, and phospholipids, accompanied by an increase in the level of 20 : 3 n-6 in phospholipids. Manku et al. [27] saw increased levels of 18 : 3 n-6 and 20 : 4 n-6 in plasma phospholipids in various populations of normal subjects and patients after administering 360 mg per day of GLA to them for periods of 10 days to 12 weeks. Jacotot et al.
[211 confirmed the increased levels of GLA, 20: 3 n-6, and 20: 4 n-6 in phospholipids after 6 months of GLA supplementation. Lastly, according to Chantreuil et al. [5] , Boberg et al. [22] , and Vericel et al. [28] , the GLA intake did not modify platelet aggregation, while Jacotot et al.
[211 reported a significant decrease in the platelet aggregation index after 6 months of GLA supplementation. It should also be noted that Chantreuil et al [5] did not observe any modification in the plasma levels of beta-thromboglobulin, thromboxane P, or PGE1.
In conclusion, this study demonstrates the dose-dependent effect of GLA intake on blood cholesterol levels in healthy subjects. It also shows that, although the variations in the fatty acid composition of phospholipids were minor, the increase in linoleic acid metabolites was sufficient to induce significant modifications in cholesterol metabolism. These modifications proceed from the intervention of several mechanisms at different steps of the metabolism. Particularly, the effect of GLA on the apoprotein synthesis can be anticipated as shown by the increased level of apoprotein A1. So the GLA intake, which modifies the PUFA duality and the level of apoprotein Al in HDL, may produce to a new distribution of HDL particles, which are known to be heterogenous, or may influence their structure or both. This in turn may affect the cholesterol metabolism by the way of cellular cholesterol efflux. This mechanism would explain partly the beneficial role of PU FA and their derivatives in cholesterolemia. Further experiments are needed to confirm this hypothesis as well as other aspects concerning cholesterol exchanges between lipoproteins or between lipoproteins and tissues, in healthy subjects or in patients with dysllpoprotelnemla in the context of sufficient intake of GLA to induce significant effects on blood lipids.
